Group urges speedier approvals for badly needed antibiotics
Infectious-disease doctors have proposed a speedier, easier approval process for drug companies developing antibiotics against untreatable illnesses. The Infectious Diseases Society of America (IDSA)...
View ArticleGenentech, 23andMe to study genetic response to breast cancer drug
Personal-genomics company 23andMe, based in Mountain View, California, and biotechnology firm Genentech, based in San Francisco, are recruiting patients with breast cancer to study genetic predictors...
View ArticleClik here to view.
Drug approval (and rejection) highlights from 2012
Another year, another round of approvals, mixed reviews and high-profile failures. We look back on which medicines made the headlines. GREEN LIGHT Xeljanz (tofacitinib) In November, the US Food and...
View ArticleClik here to view.
Seeing through the smoke with the help of research: a conversation with Helen...
NIH Most people stopped doubting the dangers of tobacco long ago. And yet, tobacco products continue to adorn the checkout kiosks of convenience stores and appear in the pages of magazines. The...
View Article
